Patents Represented by Attorney James Kanagy
  • Patent number: 5869677
    Abstract: The present invention relates to novel 3,3-(disubstituted)cyclohexan-1-carboxylate monomers and related compounds, pharmaceutical compositions containing these compounds, and their use in treating allergic and inflammatory diseases and for inhibiting the production of Tumor Necrosis Factor (TNF).
    Type: Grant
    Filed: February 27, 1996
    Date of Patent: February 9, 1999
    Assignee: SmithKline Beecham Corporation
    Inventors: Siegfried B. Christensen, IV, Joseph M. Karpinski, M. Dominic Ryan, Paul E. Bender
  • Patent number: 5409934
    Type: Grant
    Filed: July 7, 1993
    Date of Patent: April 25, 1995
    Inventors: David G. Smith, Derek R. Buckle, Ashley E. Fenwick
  • Patent number: 4923884
    Abstract: Retinoid-like activity is exhibited by compounds of the formula ##STR1## wherein A is pyridyl, furyl, thienyl, pyridazinyl, pyrimidinyl or pyrazinyl; n is 0-5; and B is H, --COOH and its esters, amides and pharmaceutically acceptable salts, --CHO and its acetal derivatives, --COR.sub.1 and its ketal derivatives where R.sub.1 is --(CH.sub.2).sub.n CH.sub.3 where n is defined above, or --CH.sub.2 OH and its ether and acyl ester derivatives; or a pharmaceutically acceptable salt.
    Type: Grant
    Filed: April 1, 1988
    Date of Patent: May 8, 1990
    Assignee: Allergan, Inc.
    Inventor: Roshantha A. S. Chandraratna
  • Patent number: 4782946
    Abstract: A hydration device and kit are provided for effecting the hydration of a dehydrated soft contact lens resident within the cavity of a mold element in which the lens was formed.
    Type: Grant
    Filed: September 17, 1987
    Date of Patent: November 8, 1988
    Assignee: Allergan, Inc.
    Inventor: Martin M. Pollak
  • Patent number: 4725620
    Abstract: Achiral compounds of a 2H-pyran-2,6(3H)-dione derivative of the formula ##STR1## or a pharmaceutically acceptable salt thereof, where R is --(CH.sub.2).sub.m OH or --CH((CH.sub.2).sub.n CH.sub.2 OH).sub.2 where m is 1-5 and n is 0-4. These compounds are useful in the treatment of allergic conditions.
    Type: Grant
    Filed: September 10, 1986
    Date of Patent: February 16, 1988
    Assignee: Allergan, Inc.
    Inventors: Michael E. Garst, Charles Gluchowski, Lester J. Kaplan
  • Patent number: D360760
    Type: Grant
    Filed: June 18, 1992
    Date of Patent: August 1, 1995
    Assignee: Lingner & Fischer GmbH
    Inventor: Hans Halm